Shuang G Zhao

Shuang G Zhao

UNVERIFIED PROFILE

Are you Shuang G Zhao?   Register this Author

Register author
Shuang G Zhao

Shuang G Zhao

Publications by authors named "Shuang G Zhao"

Are you Shuang G Zhao?   Register this Author

39Publications

1525Reads

40Profile Views

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer.

J Clin Oncol 2019 Oct 16:JCO1900761. Epub 2019 Oct 16.

Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.00761DOI Listing
October 2019

Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types.

Clin Cancer Res 2019 Jul 22;25(14):4290-4299. Epub 2019 Apr 22.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-0404DOI Listing
July 2019

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

Cell 2018 07 19;174(3):758-769.e9. Epub 2018 Jul 19.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA; Department of Radiation Oncology, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2018.06.039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425931PMC
July 2018

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

J Clin Oncol 2018 02 29;36(6):581-590. Epub 2017 Nov 29.

Daniel E. Spratt, Robert T. Dess, Adam Cole, Shuang G. Zhao, and Rohit Mehra, University of Michigan, Ann Arbor; Firas Abdollah, Henry Ford Health System, Detroit, MI; Jingbin Zhang, María Santiago-Jiménez, Lucia L.C. Lam, Jijumon Chelliserry, Marguerite du Plessis, Voleak Choeurng, Maria Aranes, Tyler Kolisnik, Jennifer Margrave, Jason Alter, Jennifer Jordan, Christine Buerki, Kasra Yousefi, Zaid Haddad, and Elai Davicioni, GenomeDx Biosciences, Vancouver, British Columbia, Canada; John W. Davis, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert B. Den, Adam P. Dicker, and Edouard J. Trabulsi, Thomas Jefferson University, Philadelphia, PA; Christopher J. Kane, University of California San Diego, San Diego; Edward Uchio, University of California Irvine; Josh M. Randall, Orange County Urology Associates, Irvine; Hao Nguyen, Peter R. Carroll and Felix Y. Feng, University of California San Francisco, San Francisco, CA; Alan Pollack and Radka Stoyanova, University of Miami, Miami, FL; Ashley E. Ross, Johns Hopkins School of Medicine, Baltimore, MD; Andrew G. Glass and Sheila Weinmann, Kaiser Permanente Northwest, Portland, OR; Stacy Loeb, New York University; Ashutosh Tewari, Icahn School of Medicine at Mount Sinai, New York, NY; Edward M. Schaeffer, Northwestern University, Evanston, IL; Eric A. Klein, Cleveland Clinic, Cleveland, OH; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; and Paul L. Nguyen, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.2940
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.2940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530900PMC
February 2018

Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease.

J Clin Oncol 2017 Jun 30;35(18):1991-1998. Epub 2017 Mar 30.

Daniel E. Spratt and Shuang G. Zhao, University of Michigan, Ann Arbor; Firas Abdollah, Henry Ford Health System, Detroit, MI; Kasra Yousefi, Samineh Deheshi, Jingbin Zhang, Lucia L.C. Lam, Marguerite du Plessis, Voleak Choeurng, Zaid Haddad, Christine Buerki, and Elai Davicioni, GenomeDx Biosciences, Vancouver, British Columbia, Canada; Ashley E. Ross and Bruce J. Trock, Johns Hopkins Hospital, Baltimore, MD; Robert B. Den and Adam P. Dicker, Thomas Jefferson University, Philadelphia, PA; Edward M. Schaeffer, Northwestern University, Evanston, IL; Andrew G. Glass and Sheila Weinmann, Center for Health Research, Kaiser Permanente Northwest, Portland, OR; Stephen J. Freedland, Cedars-Sinai Medical Center, Los Angeles; Felix Y. Feng, University of California, San Francisco, CA; Eric A. Klein, Cleveland Clinic, Cleveland, OH; and R. Jeffrey Karnes, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.2811DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530581PMC
June 2017

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

Proc Natl Acad Sci U S A 2017 06 13;114(26):E5207-E5215. Epub 2017 Jun 13.

Division of Molecular and Cellular Oncology, Department of Medical Oncology, Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215;

View Article

Download full-text PDF

Source
http://www.pnas.org/lookup/doi/10.1073/pnas.1617467114
Publisher Site
http://dx.doi.org/10.1073/pnas.1617467114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5495225PMC
June 2017

Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival.

J Urol 2017 03 7;197(3 Pt 1):662-668. Epub 2016 Sep 7.

Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.08.106DOI Listing
March 2017

Multi-institutional Analysis Shows that Low PCAT-14 Expression Associates with Poor Outcomes in Prostate Cancer.

Eur Urol 2017 02 22;71(2):257-266. Epub 2016 Jul 22.

Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA; Beaumont Hospital-Dearborn, Transitional Year Program, Dearborn, MI, USA; Department of Biomedical Engineering, Washington University School of Medicine, St. Louis, MO, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.07.012DOI Listing
February 2017

Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes.

Eur Urol Focus 2016 Dec 1;2(5):532-539. Epub 2016 Apr 1.

Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2016.03.010DOI Listing
December 2016

Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.

Lancet Oncol 2016 Nov 12;17(11):1612-1620. Epub 2016 Oct 12.

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA; Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA, USA; Department of Medicine, University of California at San Francisco, San Francisco, CA, USA; Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(
Web Search
http://dx.doi.org/10.1016/S1470-2045(16)30491-0DOI Listing
November 2016

The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer.

Clin Cancer Res 2016 Apr 2;22(7):1777-86. Epub 2015 Dec 2.

Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan. Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2016/01/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-1250DOI Listing
April 2016

Development and validation of a novel platform-independent metastasis signature in human breast cancer.

PLoS One 2015 14;10(5):e0126631. Epub 2015 May 14.

Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, United States of America; Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126631PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431866PMC
February 2016